This case presents a woman in her late 50s with hidradenitis suppurativa (HS) who presented for weight loss, syncope and ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

Targeted therapies have significantly improved the prognosis of patients with CML and newer agents are currently in clinical development.

It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

The combination of a hypomethylating agent with venetoclax is standard of care in acute myeloid leukaemia. We investigated the safety and activity of the first totally oral combination of decitabine ...

Objectives (1) Describe how the risk of major adverse cardiovascular events (MACE) in individuals with chronic myeloid leukaemia (CML) has evolved; (2) evaluate the risk of MACE associated with the ...

Anemia cases attributable to chronic kidney disease (CKD) continue to rise globally since 1990, but years lived in disability (YLD) rates have declined.

It’s hard readjusting to daily activities after undergoing treatment for chronic myeloid leukemia (CML), a blood and bone marrow disease. You’re not alone. About 1 in 526 people will get CML in their ...